Acta Pharmaceutica Sinica B(2023年06期)
藥學(xué)學(xué)報(bào)(英文版)

目 錄

• Editor Profile: Guest Editor of Special Column on Delivery Nanotechnologies to Modulate the Immune System and Combat Inflammation and Infection
• Editorial of Special Column on Delivery Nanotechnologies to Modulate the Immune System and Combat Inflammation and Infection
• Wearable patches for transdermal drug delivery
• Functional biomaterials for comprehensive periodontitis therapy
• Recent progress in application of nanovaccines for enhancing mucosal immune responses
• Light-responsive nanomedicine for cancer immunotherapy
• Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries
• Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
• Pathophysiology of obesity and its associated diseases
• Targeting histone deacetylases for cancer therapy: Trends and challenges
• Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis
• Emerging trends in organ-on-a-chip systems for drug screening
• Intelligent nanotherapeutic strategies for the delivery of CRISPR system
• The feasibility of oral targeted drug delivery: Gut immune to particulates?
• ETCM v2.0: An update with comprehensive resource and rich annotations for traditional Chinese medicine
• Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
• Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
• Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations
• Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis
• The suppression of cervical cancer ferroptosis by macrophages: The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes
• GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinsonu0027s disease
• Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling
• Corynoxine B targets at HMGB1/2 to enhance autophagy for α-synuclein clearance in fly and rodent models of Parkinsonu0027s disease
• Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations
• Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery
• Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
• Novel discovery of schisandrin A regulating the interplay of autophagy and apoptosis in oligoasthenospermia by targeting SCF/c-kit and TRPV1 via biosensors
• Manipulation of IME4 expression, a global regulation strategy for metabolic engineering in Saccharomyces cerevisiae
• Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
• Five trends of Chinau0027s pharmaceutical industry in 2022